Abstract
Isolated Growth hormone deficiency is an important and treatable cause of short stature. However, it is often difficult to diagnose the condition with certainty due to the lack of a single robust diagnostic test. Short children, other than those with the classical phenotype of immature chubby facies, truncal obesity and micropenis in boys, or those with history of cranial lesions with known association with hypopituitarism, should be evaluated for growth hormone deficiency only after excluding the other more common conditions. These children typically have height markedly below that expected for their midparental height with low height velocity and delayed bone age. Growth hormone levels should be checked by provocative testing, after ensuring that the child is euthyroid, and after priming with sex steroids if indicated. Low levels of Insulin-like growth factor 1 and Insulin-like growth factor binding protein 3 and pituitary abnormalities on neuroimaging provide important corroborative evidence to the diagnosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tattersall R. A history of growth hormone. Horm Res. 1996;46:236–47.
Ayyar VS. History of growth hormone therapy. Indian J Endocrinol Metab. 2011;15:S162–S165.
Guyda HJ. Growth hormone testing and the short child. Pediatr Res. 2000;48:579–80.
Carrillo AA, Bao Y. Hormonal dynamic tests and genetic tests used in pediatric endocrinology. In: Lifshitz F, editor. Pediatric Endocrinology, 5thed. New York: Informa Healthcare; 2007.p.737–67.
Domené HM, Bengolea SV, Martínez AS, Ropelato MG, Pennisi P, Scaglia P, et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med. 2004;350:570–7.
Rosenbloom AL, Connor EL. Hypopituitarism and other disorders of the growth hormone–insulin-like growth factor-I axis. In: Lifshitz F, editor. Pediatric Endocrinology. 5thed. New York: Informa Healthcare; 2007.p.65–99.
Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and Adolescence: Summary statement of the GH research society. J Clin Endocrinol Metab. 2000;85:3990–3.
Marin GA, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab. 1994;79:537–41.
Gonc EN, Yordam N, Kandemir N, Alikasifoglu A. Comparison of stimulated growth hormone levels in primed versus unprimed provocative tests. The effect of various testosterone doses on growth hormone levels. Horm Res. 2001;56:32–7
Murray PG, Dattani MT, Clayton PE. Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Arch Dis Child. 2016;101:96–100.
Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86:361–97.
Zadik Z, Chalew SA, Kowarski A. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab. 1990;71:932–6.
Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J ClinEndocrinolMetab. 1996;81:3323–7.
Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, et al. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. J Clin Endocrinol Metab. 1999;84:1174–83.
Bright GM, Julius JR, Lima J, Blethen SL. Growth hormone stimulation test results as predictors of recombinant human growth hormone treatment outcomes: preliminary analysis of the national cooperative growth study database. Pediatrics. 1999;104:1028–31.
Fujieda K, Hanew K, Hirano T, Igarashi Y, Nishi Y, Tachibana K, et al. Growth response to growth hormone therapy in patients with different degrees of growth hormone deficiency. Endocr J. 1996;43:S19–S25.
Clemmons DR. Role of insulin-like growth factor-I in diagnosis and management of acromegaly. Endocr Pract. 2004;10:362–71.
Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, et al. Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab. 2005;90:6028–34.
Dehiya RK, Deepa B, Chhaya K, Desai MP. Insulin like growth factor-I, insulin like growth factor binding protein-3 and acid labile subunit levels in healthy children and adolescents residing in Mumbai suburbs. Indian Pediatr. 2000;37:990–7.
Lofqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Wikland KA. Reference values for IGF-I throughout childhood and adolescence: Amodel that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab. 2001;86:5870–6.
Lofqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab. 2005;90:1420–7.
Cianfarani S, Tondinelli T, Spadoni GL, Scirè G, Boemi S, Boscherini B. Height velocity and IGF I assessment in the diagnosis of childhood onset GH insufficiency: Do we still need a second GH stimulation test? J Clin Endocrinol Metab. 2002;57:161–7.
Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, et al. Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab. 2005;90:6028–34.
Pampanini V, Pedicelli S, Gubinelli J, Scirè G, Cappa M, Boscherini B, et al. Brain magnetic resonance imaging as first-line investigation for growth hormone deficiency diagnosis in early childhood. Horm Res Paediatr. 2015;84:323–30.
Alatzoglou KS, Dattani MT. Genetic causes and treatment of isolated growth hormone deficiency—an update. Nat Rev Endocrinol. 2010;6:562–76.
Mullis PE. Genetic control of growth. Eur J Endocrinol. 2005;152:11–31.
Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). Availablefrom:http://www.ncbi.nlm.nih.gov/omim/. Accessed January 01, 2017.
Desai MP, Mithbawkar SM, Upadhye PS, Rao SC, Bhatia V, Vijaykumar M. Molecular genetic studies in isolated growth hormone deficiency (IGHD). Indian J Pediatr. 2013;80:623–30.
Birla S, Khadgawat R, Jyotsna VP, Jain V, Garg MK, Bhalla A, et al. Identification of novel PROP1 and POU1F1mutations in patients with combined pituitary hormone deficiency. Horm Metab Res. 2016;48:822–7.
Birla S, Khadgawat R, Jyotsna VP, Jain V, Garg MK, Bhalla AS, et al. Identification of novel GHRHR and GH1 mutations in patients with isolated growth hormone deficiency. Growth Horm IGF Res. 2016;29:50–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vyas, V., Kumar, A. & Jain, V. Growth hormone deficiency in children: From suspecting to diagnosing. Indian Pediatr 54, 955–960 (2017). https://doi.org/10.1007/s13312-017-1190-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-017-1190-3